As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

For gene therapy developers, every key milestone significantly influences long-term success and the timeline for commercialisation. Yet, amidst this pivotal moment, a crucial question looms: ...

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial supply, ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic ...

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about ...

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...